BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15888759)

  • 1. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN).
    Pivot X; Kataja VV; Jelic S;
    Ann Oncol; 2005; 16 Suppl 1():i62-3. PubMed ID: 15888759
    [No Abstract]   [Full Text] [Related]  

  • 2. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck.
    Pivot X;
    Ann Oncol; 2003 Jul; 14(7):1014-5. PubMed ID: 12853341
    [No Abstract]   [Full Text] [Related]  

  • 3. Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Pivot X; Villanueva C
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii65-6. PubMed ID: 17491053
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options.
    Licitra L; Locati LD; Bossi P
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii200-3. PubMed ID: 18790949
    [No Abstract]   [Full Text] [Related]  

  • 5. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 7. RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas.
    Clin Adv Hematol Oncol; 2007 Feb; 5(2):79-81. PubMed ID: 17344795
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy after surgery and radiation for stage III and IV head and neck cancer.
    Huang AT; Cole TB; Fishburn R; Jelovsek SB
    Ann Surg; 1984 Aug; 200(2):195-9. PubMed ID: 6465974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New concepts in radiotherapy for advanced squamous cell carcinoma of the head and neck.
    Poulsen MG
    Aust N Z J Surg; 1992 Sep; 62(9):702-8. PubMed ID: 1520152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.
    Hong WK
    Int J Radiat Oncol Biol Phys; 1992; 23(4):885-6. PubMed ID: 1618679
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Haas ML; Van Echo DA; Haddad R; Jacobs MC; Levy S; Gray WC; Ord RA; Conley BA
    Cancer; 2001 Feb; 91(3):548-54. PubMed ID: 11169937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy.
    Bingham HG
    Surg Clin North Am; 1986 Feb; 66(1):183-8. PubMed ID: 2418517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

  • 14. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Grégoire V; Lefebvre JL; Licitra L; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v184-6. PubMed ID: 20555077
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential chemosurgery for advanced head and neck cancer: another pathway in a complex maze?
    Robbins KT
    Ann Surg Oncol; 2003 Jul; 10(6):593-5. PubMed ID: 12839842
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of preoperative chemotherapy: where do we go from here?
    Wolf GT
    Am J Otolaryngol; 1984; 5(2):77-9. PubMed ID: 6496867
    [No Abstract]   [Full Text] [Related]  

  • 17. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
    Haddad R; Tishler RB; Norris CM; Mahadevan A; Busse P; Wirth L; Goguen LA; Sullivan CA; Costello R; Case MA; Posner MR
    Oncologist; 2003; 8(1):35-44. PubMed ID: 12604730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic chemotherapy for squamous cell head and neck cancer.
    Adelstein DJ
    Expert Opin Pharmacother; 2003 Dec; 4(12):2151-63. PubMed ID: 14640914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
    Fountzilas G; Nicolaou A; Sridhar K; Sideras T; Haritanti A; Anastasakis C; Delis V; Vritsios A; Daniilidis J
    Arch Otorhinolaryngol; 1989; 246(5):373-7. PubMed ID: 2480104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.